PKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PagePKC 412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (??, ??, ??), PDFR??, VEGFR2, Syk, PKC??, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity.
More Information Supplier PageAvanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction
More Information Supplier PageAvanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction
More Information Supplier PageAvanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction
More Information Supplier PageAvanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction
More Information Supplier PageTasquinimod is an orally active antiangiogenic agent by allosterically inhibiting HDAC4 signalling.
More Information Supplier PageTasquinimod is an orally active antiangiogenic agent by allosterically inhibiting HDAC4 signalling.
More Information Supplier Page
